UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites ▼ | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A8C6EI71 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8B7H6K6 | P2X purinoceptor |
|
1 | 0 |
|
A0A8B7WTL2 | ATP receptor |
|
1 | 0 |
|
A0A8C5UQZ8 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C5XIQ8 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A8B7X5G2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8B7F5G4 | Angiotensin-converting enzyme |
|
1 | 0 |
|
A0A8C5VDH5 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
Q2QL85 | Protein Wnt-2 |
|
1 | 0 |
|
A0A8C5XSV1 | Pannexin |
|
1 | 0 |
|
A0A8C5UPJ2 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A8B7HCZ2 | P2X purinoceptor |
|
1 | 0 |
|
A0A8C5XUW1 | Hemopexin |
|
1 | 0 |
|
A0A8C5YFC7 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8B7FBV1 | P2X purinoceptor |
|
1 | 0 |
|
A0A8B7GUI5 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8B7X780 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C5XVL1 | Potassium two pore domain channel subfamily K member 16 |
|
1 | 0 |
|
A0A8B7GUF1 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8B7GUM2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8B7GZ60 | Peptidyl-glycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A8B7G6D9 | Hyaluronidase |
|
1 | 0 |
|
I1E390 | Tartrate-resistant acid phosphatase type 5 (Fragment) |
|
1 | 0 |
|
A0A8C5XY14 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8B7X5G3 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024